Common use of Compliance with Global Trade Controls Clause in Contracts

Compliance with Global Trade Controls. The activities covered by this Agreement may be subject to Global Trade Control Laws. Parties will perform their respective obligations under this Agreement in full compliance with all applicable Global Trade Control Laws. 7.7.1 Each Party represents and warrants that such party and its respective owners, directors, and officers are neither a Restricted Party, nor owned or controlled by a Restricted Party. With respect to the activities performed under this Agreement, each Party confirms that Affiliates, agents, employees, or subcontractors directly or indirectly involved in the activities contemplated under this Agreement are not Restricted Parties and that no such Restricted Parties will be engaged in any activities contemplated under this Agreement or delegated any activities contemplated under this Agreement. In the event that any of these representations change during the Term of this Agreement, the Party connected with such a person or entity will immediately inform the other Party and suspend all related activities and payments under this Agreement until the Parties agree to move forward. specified in Section 2.1, to the public on a regular basis or as required for public health reasons and according to Israeli laws, or prevent MoH from possessing and analyzing such data, independent of this agreement and making publications thereof. Nothing in this Agreement shall prevent PFIZER from making publications using publicly available data. All publications involving the Project, will acknowledge the role of MoH and Pfizer in the Project. Without derogating from the generality of the above, to the extent that PFIZER and MoH cannot agree on a joint publication within a reasonable time, or to the extent that PFIZER or the MoH wishes to make further publications of data and results from this Agreement other than a joint publication, each Party will provide to the other Party with a copy of the publication days prior to the date of submission for publication or of public disclosure to review such material. During its review period, the other Party may provide input, make factual corrections, and request the deletion of any reference to the other Party’s Confidential Information from the proposed disclosure or publication. All disclosures and publications must expressly acknowledge the other Party, unless such Party objects to such acknowledgment. To the extent the Parties cannot resolve disputes regarding publications they shall escalate such matters to a good faith discussion between PFIZER’s and Xxxxxx Xxxxx-Xxxxx, MD, MPH, MBA.

Compliance with Global Trade Controls. The activities covered by this Agreement may be subject to Global Trade Control Laws. Parties will perform their respective obligations under this Agreement in full compliance with all applicable Global Trade Control Laws. 7.7.1 Each Party represents and warrants that such party and its respective owners, directors, and officers are neither a Restricted Party, nor owned or controlled by a Restricted Party. With respect to the activities performed under this Agreement, each Party confirms that Affiliates, agents, employees, or subcontractors directly or indirectly involved in the activities contemplated under this Agreement are not Restricted Parties and that no such Restricted Parties will be engaged in any activities contemplated under this Agreement or delegated any activities contemplated under this Agreement. In the event that any of these representations change during the Term of this Agreement, the Party connected with such a person or entity will immediately inform the other Party and suspend all related activities and payments under this Agreement until the Parties agree to move forward. specified in Section 2.1, to the public on a regular basis or as required for public health reasons and according to Israeli laws, or prevent MoH from possessing and analyzing such data, independent of this agreement and making publications thereof. Nothing in this Agreement shall prevent PFIZER from making publications using publicly available data. All publications involving the Project, will acknowledge the role of MoH XxX and Pfizer in the Project. Without derogating from the generality of the above, to the extent that PFIZER and MoH cannot agree on a joint publication within a reasonable time, or to the extent that PFIZER or the MoH wishes to make further publications of data and results from this Agreement other than a joint publication, each Party will provide to the other Party with a copy of the publication days prior to the date of submission for publication or of public disclosure to review such material. During its review period, the other Party may provide input, make factual corrections, and request the deletion of any reference to the other Party’s Confidential Information from the proposed disclosure or publication. All disclosures and publications must expressly acknowledge the other Party, unless such Party objects to such acknowledgment. To the extent the Parties cannot resolve disputes regarding publications they shall escalate such matters to a good faith discussion between PFIZERXXXXXX’s and Xxxxxx Xxxxx-Xxxxx, MD, MPH, MBA.